Spots Global Cancer Trial Database for rt
Every month we try and update this database with for rt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiation Therapy and Cardiac Enzymes | NCT00777751 | Tumor | 18 Years - | M.D. Anderson Cancer Center | ||
| Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT) | NCT05761054 | Soft Tissue Sar... | RT | 18 Years - | Azienda Ospedaliero-Universitaria Careggi | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| NBTXR3 With or Without Cetuximab in LA-HNSCC | NCT04892173 | Locally Advance... Aged | NBTXR3 Cetuximab Radiation Thera... | 65 Years - | Nanobiotix | |
| LAM561 With RT and TMZ for Adults With Glioblastoma | NCT04250922 | Primary Gliobla... Glioblastoma Mu... | LAM561 TMZ RT | 18 Years - 75 Years | Laminar Pharmaceuticals | |
| Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | NCT00631527 | Prostate Cancer | Leuprolide Goserelin Sunitinib Malat... Casodex Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Targeting the Tumor Microenvironment in R/M SCCHN | NCT03844763 | Head and Neck C... | Avelumab CTX RT | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies | NCT05828589 | Relapsed Non-Ho... Refractory Non-... Relapsed Chroni... Refractory Chro... Relapsed Follic... Relapsed Margin... Relapse Diffuse... Relapsed Small ... Refractory Foll... Refractory Marg... Refractory Smal... Richter Transfo... Refractory Diff... Transformed Non... | BGB-21447 | 18 Years - | BeiGene | |
| Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis | NCT05068453 | Melanoma Stage ... | Recombinant Onc... Recombinant hum... RT | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Phase II Evaluation of Exhaled Nitric Oxide (NO) | NCT01392144 | Lung Cancer | Nitric oxide br... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies | NCT05828589 | Relapsed Non-Ho... Refractory Non-... Relapsed Chroni... Refractory Chro... Relapsed Follic... Relapsed Margin... Relapse Diffuse... Relapsed Small ... Refractory Foll... Refractory Marg... Refractory Smal... Richter Transfo... Refractory Diff... Transformed Non... | BGB-21447 | 18 Years - | BeiGene | |
| Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients | NCT02253238 | Head and Neck C... | Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit... | 18 Years - | M.D. Anderson Cancer Center | |
| A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT01303237 | Unresectable Lo... LA SCCHN | Cetuximab + RT | - | Merck KGaA, Darmstadt, Germany | |
| Vorinostat Plus Radiation Therapy in Pancreatic Cancer | NCT00831493 | Pancreatic Canc... | Chemoradiation ... Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
| Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
| Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma | NCT00502411 | Soft Tissue Sar... | Doxorubicin Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation | NCT01627080 | Esophageal Canc... | Cardiac Biomark... | 18 Years - | M.D. Anderson Cancer Center | |
| Vorinostat Plus Radiation Therapy in Pancreatic Cancer | NCT00831493 | Pancreatic Canc... | Chemoradiation ... Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
| Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy | NCT01410942 | Prostate Cancer | Placebo Methylphenidate Counseling Sess... Sham Exercise Standardized Ex... Cognitive Behav... | 18 Years - | M.D. Anderson Cancer Center | |
| Targeting the Tumor Microenvironment in R/M SCCHN | NCT03844763 | Head and Neck C... | Avelumab CTX RT | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| Phase II Evaluation of Exhaled Nitric Oxide (NO) | NCT01392144 | Lung Cancer | Nitric oxide br... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi | NCT03939845 | Carcinoma, Hepa... | RT TACE | 18 Years - | Shanghai Zhongshan Hospital | |
| Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT) | NCT02724618 | Prostate Cancer | Curcumin RT Placebo | - | Shahid Beheshti University of Medical Sciences | |
| The CAROLE (CArdiac Related Oncologic Late Effects) Study | NCT03235427 | Coronary Artery... Cardiac Disease Cardiac Toxicit... Radiation Radiation Thera... Atherosclerotic... Cardiotoxicity Breast Cancer Lung Cancer Lymphoma Cancer Carcinoma, Intr... | 26 Years - 78 Years | Northwell Health | ||
| Proton Therapy and Bevacizumab for Primary Liver Tumors | NCT00426829 | Liver Cancer Hepatocellular ... Cholangiocarcin... | Bevacizumab Proton Radiatio... | - | M.D. Anderson Cancer Center | |
| 'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHL | NCT04601831 | Non-Hodgkin Lym... | Focal radiation... | 18 Years - | University of Texas Southwestern Medical Center | |
| Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma | NCT00895960 | Glioblastoma CNS Disease Brain Diseases | Dasatinib RT (Radiotherap... TMZ (Temozolomi... | 18 Years - | M.D. Anderson Cancer Center | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT01303237 | Unresectable Lo... LA SCCHN | Cetuximab + RT | - | Merck KGaA, Darmstadt, Germany | |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients | NCT02253238 | Head and Neck C... | Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit... | 18 Years - | M.D. Anderson Cancer Center | |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas). | NCT05331521 | Oligodendroglio... | CETEG PCV RT | 18 Years - | University Hospital Heidelberg | |
| Targeting the Tumor Microenvironment in R/M SCCHN | NCT03844763 | Head and Neck C... | Avelumab CTX RT | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients | NCT02253238 | Head and Neck C... | Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit... | 18 Years - | M.D. Anderson Cancer Center | |
| LAM561 With RT and TMZ for Adults With Glioblastoma | NCT04250922 | Primary Gliobla... Glioblastoma Mu... | LAM561 TMZ RT | 18 Years - 75 Years | Laminar Pharmaceuticals | |
| Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC | NCT02658097 | Stage IV Non-Sm... | Pembrolizumab Single Fraction... | 18 Years - | Case Comprehensive Cancer Center | |
| LAM561 With RT and TMZ for Adults With Glioblastoma | NCT04250922 | Primary Gliobla... Glioblastoma Mu... | LAM561 TMZ RT | 18 Years - 75 Years | Laminar Pharmaceuticals | |
| Proton Therapy and Bevacizumab for Primary Liver Tumors | NCT00426829 | Liver Cancer Hepatocellular ... Cholangiocarcin... | Bevacizumab Proton Radiatio... | - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
